HomeCompareGETVV vs MRK

GETVV vs MRK: Dividend Comparison 2026

GETVV yields 90.09% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GETVV wins by $2.52M in total portfolio value
10 years
GETVV
GETVV
● Live price
90.09%
Share price
$2.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.58M
Annual income
$809,089.52
Full GETVV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — GETVV vs MRK

📍 GETVV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGETVVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GETVV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GETVV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GETVV
Annual income on $10K today (after 15% tax)
$7,657.66/yr
After 10yr DRIP, annual income (after tax)
$687,726.09/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, GETVV beats the other by $679,397.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GETVV + MRK for your $10,000?

GETVV: 50%MRK: 50%
100% MRK50/50100% GETVV
Portfolio after 10yr
$1.32M
Annual income
$409,443.83/yr
Blended yield
31.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

GETVV
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GETVV buys
0
MRK buys
0
No recent congressional trades found for GETVV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGETVVMRK
Forward yield90.09%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$2.58M$56.8K
Annual income after 10y$809,089.52$9,798.13
Total dividends collected$2.27M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GETVV vs MRK ($10,000, DRIP)

YearGETVV PortfolioGETVV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,709$9,009.01$11,206$366.19+$8.5KGETVV
2$37,683$16,594.27$12,650$502.35+$25.0KGETVV
3$69,973$29,651.99$14,407$694.19+$55.6KGETVV
4$126,329$51,458.17$16,585$967.82+$109.7KGETVV
5$221,997$86,825.00$19,342$1,363.89+$202.7KGETVV
6$380,132$142,595.30$22,913$1,947.19+$357.2KGETVV
7$634,938$228,196.44$27,662$2,823.89+$607.3KGETVV
8$1,035,606$356,222.82$34,159$4,173.35+$1.00MGETVV
9$1,651,101$543,002.02$43,337$6,308.80+$1.61MGETVV
10$2,575,767$809,089.52$56,776$9,798.13+$2.52MGETVV

GETVV vs MRK: Complete Analysis 2026

GETVVStock

Getnet Adquirência e Serviços Para Meios de Pagamento S.A. operates in the acquiring and services market for means of payment regulated by the Council National Monetary Council and the Central Bank of Brazil. The company engages in the provision of accreditation services for commercial and service establishments for accepting credit and debit cards; capturing, transmission, and processing of data and information; management of payments and receipts made to establishments accredited to its network; and installation, uninstallation, monitoring, supply, maintenance, and leasing of equipment used in transaction capture networks. It also engages in the development and marketing or licensing of software; commercializing products or distributing services of companies that provide cadastral information; provision of technical, commercial, and logistic infrastructure services for the business related to the receipt of accounts from concessionaires, banks, and other collection documents; and issuing electronic money. The company was formerly known as Farthi Empreendimentos e Participações S.A. and changed its name to Getnet Adquirência e Serviços para Meios de Pagamento S.A. in August 2014. The company was founded in 2008 and is based in São Paulo, Brazil. Getnet Adquirência e Serviços para Meios de Pagamento S.A. operates as a subsidiary of Banco Santander (Brasil) S.A.

Full GETVV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this GETVV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GETVV vs SCHDGETVV vs JEPIGETVV vs OGETVV vs KOGETVV vs MAINGETVV vs JNJGETVV vs ABBVGETVV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.